BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9573230)

  • 21. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
    Yu XF; Matsuda Z; Yu QC; Lee TH; Essex M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3171-9. PubMed ID: 8847526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
    Dettenhofer M; Yu XF
    J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    Huang M; Orenstein JM; Martin MA; Freed EO
    J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
    Ott DE; Coren LV; Gagliardi TD; Nagashima K
    J Virol; 2005 Jul; 79(14):9038-45. PubMed ID: 15994797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
    Melamed D; Mark-Danieli M; Kenan-Eichler M; Kraus O; Castiel A; Laham N; Pupko T; Glaser F; Ben-Tal N; Bacharach E
    J Virol; 2004 Sep; 78(18):9675-88. PubMed ID: 15331700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
    Campbell S; Rein A
    J Virol; 1999 Mar; 73(3):2270-9. PubMed ID: 9971810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
    Burnett A; Spearman P
    J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
    Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organization of immature human immunodeficiency virus type 1.
    Wilk T; Gross I; Gowen BE; Rutten T; de Haas F; Welker R; Kräusslich HG; Boulanger P; Fuller SD
    J Virol; 2001 Jan; 75(2):759-71. PubMed ID: 11134289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 nucleocapsid p1 confers ESCRT pathway dependence.
    Popova E; Popov S; Göttlinger HG
    J Virol; 2010 Jul; 84(13):6590-7. PubMed ID: 20427536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.
    Votteler J; Neumann L; Hahn S; Hahn F; Rauch P; Schmidt K; Studtrucker N; Solbak SM; Fossen T; Henklein P; Ott DE; Holland G; Bannert N; Schubert U
    Retrovirology; 2011 Feb; 8():11. PubMed ID: 21324168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elements in HIV-1 Gag contributing to virus particle assembly.
    O'Carroll IP; Soheilian F; Kamata A; Nagashima K; Rein A
    Virus Res; 2013 Feb; 171(2):341-5. PubMed ID: 23099087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.